Testing for responses to the wrong SARS-CoV-2 antigen?

Lancet. 2020 Sep 5;396(10252):e23. doi: 10.1016/S0140-6736(20)31830-4. Epub 2020 Aug 28.

Authors

Carolina Rosadas¹, Paul Randell², Maryam Khan¹, Myra O McClure¹, Richard S Tedder³

Affiliations

¹ Department of Infectious Disease, Imperial College London, London, UK.
² Department of Infection and Immunity, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
³ Department of Infectious Disease, Imperial College London, London, UK; Jefferiss Research Trust Laboratories, Wright-Fleming Institute, Faculty of Medicine, Imperial College London, London W2 1PG, UK. Electronic address: r.tedder@imperial.ac.uk.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Neutralizing / analysis
Antibodies, Viral / analysis*
Betacoronavirus
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques / methods*
Coronavirus Infections / diagnosis*
Coronavirus Nucleocapsid Proteins
Humans
Nucleocapsid Proteins / immunology*
Pandemics
Phosphoproteins
Pneumonia, Viral / diagnosis*
SARS-CoV-2
Sensitivity and Specificity

Substances

Antibodies, Neutralizing
Antibodies, Viral
Coronavirus Nucleocapsid Proteins
Nucleocapsid Proteins
Phosphoproteins
nucleocapsid phosphoprotein, SARS-CoV-2

Grants and funding

MRC_/Medical Research Council/United Kingdom